Aya El Helali

Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial

Chi‐Leung Chiang, K.W. Chiu, Kenneth Sik Kwan Chan et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 137 citations

Medicine, Oncology, Radiation Oncology +16

First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration

Jordi Rodón, Hans Prenen, Adrian G. Sacher et al. · Annals of Oncology · 2024 · 96 citations · Full text

Medicine, Oncology, Pharmacology +8

MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming

Ting Wang, Fangzhou Sun, Chunxiao Li et al. · Advanced Science · 2023 · 43 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Potential Determinants for Radiation-Induced Lymphopenia in Patients With Breast Cancer Using Interpretable Machine Learning Approach

Hao Yu, Fang Chen, Ka-On Lam et al. · Frontiers in Immunology · 2022 · 33 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer

Niamh McGivern, Aya El Helali, Paul B. Mullan et al. · Oncotarget · 2017 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17